Dysregulation of microRNAs regulating survivin in CD4+T cells in multiple sclerosis

被引:13
作者
Alizadeh-Fanalou, Shahin [1 ,2 ]
Alian, Fatemeh [3 ]
Mohammadhosayni, Mina [4 ]
Rahban, Dariush [5 ]
Kheyli, Pedram Abbasi Ghasem [6 ]
Ahmadi, Majid [7 ,8 ]
机构
[1] Iran Univ Med Sci, Student Res Comm, Tehran, Iran
[2] Iran Univ Med Sci, Dept Biochem, Fac Med, Tehran, Iran
[3] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[4] Shahed Univ, Dept Immunol, Fac Med, Tehran, Iran
[5] Univ Tehran Med Sci, Sch Adv Med Technol, Dept Nanomed, Poursina St, Tehran, Iran
[6] Shiraz Univ Med Sci, Paramed Dept, Shiraz, Iran
[7] Tabriz Univ Med Sci, Stem Cell Res Ctr, Imam Reza Hosp, Daneshghah St, Tabriz, Iran
[8] Tabriz Univ Med Sci, Students Res Comm, Tabriz, Iran
关键词
Multiple sclerosis; Apoptosis; Microrna; Survivin; Birc5; gene; ACTIVATED T-LYMPHOCYTES; DOWN-REGULATION; EXPRESSION; APOPTOSIS; RISK; PROLIFERATION; POLYMORPHISMS; DISABILITY;
D O I
10.1016/j.msard.2020.102303
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Impaired elimination mechanisms of the autoreactive lymphocytes, like T lymphocytes, via apoptosis may be the cause of continues inflammatory state in multiple sclerosis (MS). BIRC5 gene codify for the survivin, which participates in the modulation of apoptosis and cell survival. The objective of this study was investigation of the role of important confirmed miRNAs, including miR-335, miR-485, miR-542, and miR-708, in the regulation of survivin mRNA in the CD4+ T cells of MS cases. Methods: In this study, 50 RRMS patients as well as 50 healthy matched controls were recruited. The peripheral blood mononuclear cells (PBMCs) were isolated from whole blood samples and CD4+ T cells were prepared. After that, RNA was extracted, cDNA was synthesized, and the expression levels of miR-335, miR-485, miR-542, and miR-708 were measured using Real-time PCR. Moreover, the mRNA expression of survivin was detected. Serum level of survivin was detected using ELISA. Results: The mRNA of survivin was 2-folds upregulated in the CD4+ T cells from MS patients in comparison to the healthy controls (P = 0.0053). Serum level of survivin was higher in patients than controls. There was statistically significant downregulation of miR-485 (P = 0.001) and miR-708 (P = 0.011) in CD4+ T cells of patients compared with controls. The miR-485 downregulation had statistically significant correlation with the mRNA expression and serum level of survivin. Conclusion: miRNAs play a role in the regulation of survivin, and therefore apoptosis of CD4+ T cells, and hence are probably participating in a persistent inflammatory condition in MS patients.
引用
收藏
页数:7
相关论文
共 38 条
  • [1] Alcina A, 2019, RARE DIS IMMUNE SYST, P183, DOI 10.1007/978-3-030-03934-9_10
  • [2] Validating survivin as a cancer therapeutic target
    Altieri, DC
    [J]. NATURE REVIEWS CANCER, 2003, 3 (01) : 46 - 54
  • [3] [Anonymous], 1982, ZH NEVROPATOLOGII I
  • [4] Epigenetic Modifications and Therapy in Multiple Sclerosis
    Aslani, Saeed
    Jafari, Naser
    Javan, Mohammad Reza
    Karami, Jafar
    Ahmadi, Majid
    Jafarnejad, Mahmoud
    [J]. NEUROMOLECULAR MEDICINE, 2017, 19 (01) : 11 - 23
  • [5] Apoptotic and effector pathways in autoimmunity
    Chervonsky, AV
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (06) : 684 - 688
  • [6] T-Helper 17 Cells Expand in Multiple Sclerosis and Are Inhibited by Interferon-β
    Durelli, Luca
    Conti, Laura
    Clerico, Marinella
    Boselli, Daniela
    Contessa, Giulia
    Ripellino, Paolo
    Ferrero, Bruno
    Eid, Pierre
    Novelli, Francesco
    [J]. ANNALS OF NEUROLOGY, 2009, 65 (05) : 499 - 509
  • [7] Survivin and autoimmunity; the ins and outs
    Ebrahimiyan, Hamidreza
    Aslani, Saeed
    Rezaei, Nima
    Jamshidi, Ahmadreza
    Mahmoudi, Mahdi
    [J]. IMMUNOLOGY LETTERS, 2018, 193 : 14 - 24
  • [8] MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2
    Gao, Feng
    Wu, Hao
    Wang, Rui
    Guo, Yang
    Zhang, Zefeng
    Wang, Tao
    Zhang, Guoliang
    Liu, Changjiang
    Liu, Junfeng
    [J]. BIOENGINEERED, 2019, 10 (01) : 1 - 12
  • [9] A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future
    Gholamzad, Mehrdad
    Ebtekar, Masoumeh
    Ardestani, Mehdi Shafiee
    Azimi, Maryam
    Mahmodi, Zeinab
    Mousavi, Mohammad Javad
    Aslani, Saeed
    [J]. INFLAMMATION RESEARCH, 2019, 68 (01) : 25 - 38
  • [10] Goldenberg Marvin M, 2012, P T, V37, P175